SPC471
dolutegravir or a pharmaceutically acceptable salt, including dolutegravir sodium, and lamivudine
:
Umsókn:
3.6.2024:
15.7.2024
:
2.7.2034:
DOVATO
3.6.2024
15.7.2024
2.7.2034
:
EU/1/19/1370:
19.7.2019
:
EU/1/19/1370:
1.7.2019
:
VIIV Healthcare Company:
251 Little Falls Drive, Wilmington, DE 19808 US
:
Tego IP ehf.:
Pósthólf 8129, 128 Reykjavík